Concepts (58)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hypertension, Pulmonary | 1 | 2017 | 15 | 0.530 |
Why?
|
| Bronchopulmonary Dysplasia | 1 | 2017 | 15 | 0.530 |
Why?
|
| Lactoferrin | 2 | 2020 | 9 | 0.340 |
Why?
|
| Intensive Care Units, Neonatal | 2 | 2020 | 172 | 0.270 |
Why?
|
| Infant, Newborn | 5 | 2020 | 535 | 0.260 |
Why?
|
| Infant, Premature | 4 | 2020 | 181 | 0.230 |
Why?
|
| Infant, Very Low Birth Weight | 3 | 2020 | 153 | 0.190 |
Why?
|
| Milk, Human | 2 | 2020 | 156 | 0.180 |
Why?
|
| Birth Weight | 2 | 2020 | 38 | 0.170 |
Why?
|
| Gastric Mucosa | 1 | 2020 | 9 | 0.170 |
Why?
|
| Gestational Age | 2 | 2020 | 73 | 0.170 |
Why?
|
| Cholestasis | 1 | 2020 | 7 | 0.170 |
Why?
|
| Milk Banks | 1 | 2020 | 18 | 0.170 |
Why?
|
| Microbiota | 1 | 2020 | 64 | 0.160 |
Why?
|
| Virginia | 1 | 2017 | 3 | 0.130 |
Why?
|
| Statistics as Topic | 1 | 2017 | 84 | 0.130 |
Why?
|
| Age of Onset | 1 | 2017 | 73 | 0.130 |
Why?
|
| Echocardiography | 1 | 2017 | 66 | 0.130 |
Why?
|
| Hospital Mortality | 1 | 2017 | 132 | 0.120 |
Why?
|
| Retrospective Studies | 2 | 2020 | 3036 | 0.100 |
Why?
|
| Tetrahydronaphthalenes | 2 | 2009 | 2 | 0.090 |
Why?
|
| Retinoid X Receptors | 2 | 2009 | 3 | 0.090 |
Why?
|
| Cattle | 2 | 2020 | 111 | 0.080 |
Why?
|
| Dietary Supplements | 2 | 2020 | 54 | 0.080 |
Why?
|
| Humans | 7 | 2020 | 23152 | 0.080 |
Why?
|
| Retinoids | 1 | 2009 | 5 | 0.080 |
Why?
|
| Thiazolidinediones | 1 | 2009 | 7 | 0.080 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2009 | 22 | 0.080 |
Why?
|
| Melanoma | 1 | 2009 | 47 | 0.070 |
Why?
|
| Animals | 4 | 2020 | 3253 | 0.070 |
Why?
|
| Thyroid Neoplasms | 1 | 2008 | 44 | 0.070 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2009 | 232 | 0.070 |
Why?
|
| Carcinoma | 1 | 2008 | 66 | 0.070 |
Why?
|
| Antineoplastic Agents | 1 | 2008 | 194 | 0.060 |
Why?
|
| Male | 1 | 2017 | 12524 | 0.050 |
Why?
|
| Female | 1 | 2017 | 13031 | 0.040 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2020 | 78 | 0.040 |
Why?
|
| Infant Formula | 1 | 2020 | 18 | 0.040 |
Why?
|
| Urinary Tract Infections | 1 | 2020 | 31 | 0.040 |
Why?
|
| Infant, Premature, Diseases | 1 | 2020 | 26 | 0.040 |
Why?
|
| Enterocolitis, Necrotizing | 1 | 2020 | 36 | 0.040 |
Why?
|
| Parenteral Nutrition | 1 | 2020 | 20 | 0.040 |
Why?
|
| Enteral Nutrition | 1 | 2020 | 60 | 0.040 |
Why?
|
| Cost-Benefit Analysis | 1 | 2020 | 110 | 0.040 |
Why?
|
| Breast Feeding | 1 | 2020 | 139 | 0.040 |
Why?
|
| Xenograft Model Antitumor Assays | 2 | 2009 | 21 | 0.040 |
Why?
|
| Infant | 1 | 2020 | 480 | 0.040 |
Why?
|
| Cell Line, Tumor | 2 | 2009 | 248 | 0.030 |
Why?
|
| Prospective Studies | 1 | 2020 | 1507 | 0.030 |
Why?
|
| Mice | 2 | 2009 | 1233 | 0.030 |
Why?
|
| Benzoates | 1 | 2009 | 5 | 0.020 |
Why?
|
| PPAR gamma | 1 | 2009 | 13 | 0.020 |
Why?
|
| Ligands | 1 | 2009 | 37 | 0.020 |
Why?
|
| RNA, Small Interfering | 1 | 2009 | 76 | 0.020 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2009 | 65 | 0.020 |
Why?
|
| Cell Proliferation | 1 | 2009 | 165 | 0.020 |
Why?
|
| Mice, Nude | 1 | 2008 | 24 | 0.020 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2008 | 56 | 0.020 |
Why?
|